• A Hybrid Conference and Internet Event
• Sponsored by Latin American Ethics and Compliance Network
• Cosponsored by CETIFARMA, CANIFARM, Council of National Bioethics Commission of Mexico, International Society of Healthcare Compliance Professionals (ETHICS), National Academy of Medicine of Mexico and Pharmaceutical Compliance Forum (PCF)
• Featuring IFPMA Code Compliance Workshop, July 28, 2014 and CETIFARMA/IFPMA Mexican Compliance Roundtable, July 29, 2014
• July 29 - 31, 2014
• Onsite at the Krystal Grand Reforma Uno, Mexico City, Mexico
• Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
• Visit Website

FEATURING PUBLIC PROCUREMENT AND PHARMA PRICING UPDATE, INCLUDING GOVERNMENT TENDERS AND REGULATORY (REGISTRATION PROCESS) BY:

Patricio Marquez Macias, Esq. General Counsel, Covidien, Mexico City, Mexico Fernando M. Caleiro Palma, Esq. Executive Director, Corporate Compliance, Assurance - FIDS, EY; Executive, Instituto dos Advogados de Sao Paulo (IASP) and Fundacao Instituto de Administracao, Business School (FIA); Former Divisional Compliance Officer, Americas, Stryker, Sao Paulo, Brazil Trevor Wear, MHA, JD Partner, Sidley Austin LLP, Chicago, IL Fatima Wolff, Esq. Senior Compliance Counsel, Boston Scientific Corporation, Miami, FL, USA Claudia Navarro Senior Director RA/QA, Covidien, Miami, FL, USA (Moderator)

MEXICO CITY, MEXICO -- PHARMA UPDATE NEWS SERVICE™ -- JULY 9, 2014: The Second Latin American Pharmaceutical Compliance Congress, www.LatinAmericanPharmaCongress.com, will be held July 29 - 31, 2014 at the Krystal Grand Reforma Uno in Mexico City, Mexico.

	SECOND LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS AND BEST PRACTICES FORUM July 29 - 31, 2014
ATTEND ONSITE Melia Mexico Reforma Mexico City, Mexico	WEBCAST PARTICIPATION Live and Archived for 6 Months

KEYNOTE SPEAKERS

Eduardo Bohorquez Executive Director, Transparencia Mexicana, Mexico Chapter of Transparency International, Executive Director, The East Country Foundation, Mexico City, Mexico Joanna Groves Chief Executive Officer, International Alliance of Patients' Organizations (IAPO), London, UK Otmar Kloiber, MD, PhD Secretary General, World Medical Association, Ferney-Voltaire, France Alma Rocio Balcazar Romero Representative, Transparency International, Independent Consultant on Governance, Compliance and Corruption Risks, Bogota, Columbia Luis Villalba Executive Director, The Latin American Federation of Pharmaceutical Industries (FIFARMA), Mexico, D.F., Mexico Russell Williams President, Canada's Research-Based Pharmaceutical Companies (Rx&D), Former Member, National Assembly of Quebec, Ottawa, ON, Canada

PHARMA AND DEVICE COMPANY EXECUTIVE KEYNOTE SPEAKERS

Óscar Ferenczi Senior Vice President Latin America, Grunental, Former Head Latin America, Sandoz, Former Vice President & General Manager Brazil, and Former General Manager Chile, Peru, and Ecuado, Merck Sharp & Dohme, Miami, FL, USA Antonio Ferreira International Vice President, Janssen Latin America, part of Janssen Pharmaceutical Companies of Johnson & Johnson, Chairman, Johnson & Johnson Latin American Contribution Committee (LACC), Board Member, Council of the Americas, Miami, FL, USA Gavin French Vice President and General Manager Latin America, Edwards Lifesciences, Sao Paulo, Brazil Carlos D. Garcia, MBA President of Latin America and Canada, Novartis Latin America Services, Inc., Miami, FL, USA Miguel Salazar Hernandez President and Country Manager, Mexico, Central America and Dominican Republic, Boehringer Ingelheim Mexico S.A. de C.V., Mexico City, Mexico Martin Mercer Vice President Latin America, Astellas Pharma, Former President, International Region, Valeant Pharmaceuticals International, Inc., Former Vice President North Andes Zone, GlaxoSmithKline, Northbrook, IL, USA

LATIN AMERICAN PHARMA ASSOCIATION EXECUTIVE KEYNOTE SPEAKERS

Dr. Alfredo Hector Ahuad Medical Manager, Camara Argentina de Especialidades Medicinales, Buenos Aires, Argentina Rafael Gual Cosio, CH.E. General Director, National Chamber of Pharmaceutical Industry (CANIFARMA), Mexico City, Mexico Maria Jose Delgado General Director, Brazilian Research-based Pharmaceutical Manufacturers Association (InterFarma) Sao Paulo, Brazil Dr. Francisco de Paula Gomez Executive President, Association of Pharmaceutical Research Laboratories (AFIDRO), Bogota, D. C. - Colombia Dr. Rodolfo Lambour Executive Director, Central American Federation of Pharmaceutical Laboratories (FEDEFARMA), Guatemala María del Carmen de Sáenz Executive Director, Pharmaceutical Industry of Research of Ecuador, Quito, Ecuador Dr. Carlos Campillo Serrano President, Consejo de Ética y Transparencia de la Industria Farmacéutica (CETIFARMA), Mexico City, Mexico

MEXICAN KEYNOTE SPEAKERS

Mikel Arriola, MPP, LLM Head, Federal Commission for the Protection from Sanitary Risks (COFEPRIS), Former Head, Unit for Revenue Legislation, Ministry of Finance and Public Credit, Mexico City, Mexico Manuel H. Ruíz de Chávez, MD President, Council of National Bioethics Commission of Mexico, Former Director, Health Services Institute of Mexico City, Former Executive President, Mexican Health Foundation, Mexico City, Mexico Alberto Lifshitz Guinzberg, MD Head of Clinical Instruction and Medical Internship Medical School, National Autonomous University of Mexico, Mexico City, Mexico Enrique Ruelas, MD, MHCS, MPA President, National Academy of Medicine, Former Dean, National School of Public Health of Mexico, Former Vice Minister of Health of Mexico and Secretary of the General Health Council of Mexico, Mexico City, Mexico Alexis Serlin General Director, Novartis Mexico, Mexico City, Mexico Juan Francisco Millán Soberanes, MD General Director of Arbitration, National Commission of Medical Arbitration, Board Member, CETIFARMA, Mexico City, Mexico Julio Sotelo, MD Emeritus Researcher, National Institute, of Neurology and Neurosurgery, Representative of Mexico for Medicine, Organization for Economic Co-operation and Development (OECD), Mexico City, Mexico Carlos Banos Urquijo General Director, Eli Lilly Mexico, Mexico City, Mexico

FEATURING IFPMA CODE WORKSHOP AND ETHICAL PROMOTION ROUNDTABLE

Sponsored by International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on Monday, July 28, 2014.

Tamara Music, Manager, Influenza Vaccines & Code Compliance, IFPMA Geneva, Switzerland (Chair)

A MEXICAN COMPLIANCE ROUNDTABLE
Sponsored by CETIFARMA and IFPMA on the morning of Tuesday, July 29, 2014.
Dr. Carlos Campillo Serrano, President, Council of Ethics and Transparency of Pharmaceutical Industry (CETIFARMA), Mexico City, Mexico (Chair)

THE FOLLOWING SPECIAL SESSIONS

LATAM Compliance and Ethics - Perspectives from the C-suite LATAM Pharmaceutical Association Executive Roundtable HCP and Patient Stakeholder Dialogue Mexico Regulatory and Compliance Roundtable How the US Sunshine Act and Global Transparency Trends will Impact LATAM New Business Models and New Compliance Challenges The Use of Data Analytics in Compliance Global Code Update Roundtable Transforming the Compliance

AND MINI SUMMITS

Basic Compliance Training I, II and III MERCOSUR Region (Argentina, Brazil, Paraguay, Uruguay, Venezuela & Bolivia) Compliance Update Northern LATAM, Central America & Caribbean Compliance Update Impact of International Pharma Codes on Congresses How to Make your Compliance Program Successful Public Procurement and Pharma Pricing Update Best Practices in Monitoring Compliance of Third Parties Advanced Issues in Global Transparency, Disclosure and Aggregate Spend Debunking Analytics: Implication of Data on Compliance Monitoring Global Anti-Bribery Master Class Managing the Grey Areas of Compliance New LATAM Business Models & Related Compliance Challenges Investigations in Latin America Embedding Integrity with and beyond Compliance Training Global/LATAM Fair Market Value Update Monitoring Activity and the Concept of Line Defense

FEATURED FACULTY

Cecilia Abe, MBA LATAM Regional Compliance Officer, Sanofi-Aventis, Former Senior Compliance Lead for LATAM, AstraZeneca Pharmaceuticals, Miami, FL, USA Sergio Abreu, JD Regional Compliance Officer - LATAM, Merck KGaA, Montevideo, Uruguay Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Jonathan Edward Adams, JD, MBA Senior Associate, Baker & McKenzie, Mexico City, Mexico Eunice Alcantara Compliance and Ethics Director Brazil, Bristol Myers Squibb Co., São Paulo, Brazil Maritza Escalante Andrade Health Care Compliance Officer, Johnson & Johnson, Medical Device & Diagnostic, Mexico City, Mexico Elke Baumann Global Integrity & Compliance Director, Novartis Pharma AG, Basel, Switzerland D. Jeffrey Campbell, Esq. Principal, Porzio, Bromberg & Newman PC, President and Chief Executive Officer, Porzio Life Sciences, Morristown, NJ, USA Vanina Caniza, JD, LLM Partner, Baker & McKenzie, Buenos Aires, Argentina Anita Cava Director, Business Ethics Program, Co-Director, Ethics Programs, and Professor, Business Law, School of Business Administration, University of Miami, Miami, FL, USA Andrés Cedrón, Esq. Legal Counsel & Director of Compliance - Americas, Stryker, Miramar, FL, USA Michael R. Clarke, Esq. Vice President, Ethics and Compliance Americas, Actavis, Former Vice President and Compliance Officer, Biomet Spine and Bone Healing Technologies, Former Vice President/Chief Ethics and Compliance Officer, University of Medicine and Dentistry of New Jersey, Morristown, NJ, USA Paul Curtin, Esq. Executive Director, International Compliance, Forest Laboratories, New York, NY, USA Mauro Diaz, MBA Compliance Officer, Latin America Pharmaceuticals, GlaxoSmithKline, Rio de Janeiro, Brazil Gildas Durand Senior Manager, Ernst & Young LLP, Miami, FL, USA Esther M. Flesch, Esq. Partner, Trench, Rossi e Watanabe and Baker & McKenzie, São Paulo, Brazil Gary F. Giampetruzzi, Esq. Partner, Paul Hastings, Former Vice President and Assistant General Counsel and Head of Government Investigations, Pfizer Inc., New York, NY, USA Sandra Gonzalez, Esq. Associate, Porzio, Bromberg & Newman, Manager of Regulatory and Compliance Services, Porzio Life Sciences, LLC., Morristown, NJ, USA Nancy A. Grygiel, JD, LLM Vice President Global Corporate Compliance, Allergan, Irvine, CA, USA Jonathon L. Kellerman Principal, Pharmaceutical and Life Sciences Advisory, PwC, Florham Park, NJ, USA Adam Kozielec, CPA Manager, Corporate Internal Audit, Johnson & Johnson, New York, NY, USA Claudia Hernandez Loustalot Laclette, MA Pharma and Country Compliance Head Mexico, Novartis Corporativo, S.A. de C.V., Former Compliance and Ethics Director, Bristol-Myers Squibb, Former Compliance Manager, Eli Lilly, Mexico, City, Mexico Cesar Lara Director, Pharmaceutical and Life Sciences Advisory, PwC, Mexico City, Mexico Michael K. Loucks, Esq. Partner, Skadden Arps LLP, Former Acting United States Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC, USA Patricio Marquez Macias, Esq. General Counsel, Covidien, Mexico City, Mexico Rodrigo Salles Medina, JD, LLM Legal Director - Latin America | Medtronic Inc., Miami, FL, USA Maritza I. Munich, Esq. Chief Legal Officer, General Counsel & Corporate Secretary, Medical Card System, Inc., Former General Counsel, Mexico & Central America, The Procter & Gamble Company, Former Vice President & General Counsel - International, Wal-Mart Stores, Inc., San Juan, Puerto Rico, USA Ryan D. Murphy Partner, Pharmaceutical and Life Sciences Forensics, PwC, Chicago, IL, USA Chrisoula Nikidis Director, Ethics and Compliance, Canada's Research-Based Pharmaceutical Companies (Rx&D), Ottawa, ON, Canada Jan Oliver Huber General Secretary, Austrian Pharmaceutical Industry Association (PHARMIG), Member, IFPMA Code Compliance Network, Vienna, Austria Fernando M. Caleiro Palma, Esq. Diretor Executivo, Corporate Compliance, Assurance - FIDS, Ernst & Young, Executive, Instituto dos Advogados de São Paulo (IASP) and Fundação Instituto de Administração, Business School (FIA), São Paulo, Brazil Louis Ramos, Esq. Lead Compliance Counsel for Latin America, International R&D and Manufacturing, Pfizer Inc.; Former Assistant United States Attorney, United States Attorney's Office for the District of Columbia, Washington, DC, USA Brian Riewerts Principal, Global Governance, Risk and Compliance Leader, Pharmaceutical and Life Sciences Advisory, PwC, Baltimore, MD, USA Jeffrey Rosenbaum, MBA Senior Vice President and Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance, Novartis Oncology, Boston, MA, USA Christian-Claus Roth Head of Congresses and Conventions, Novartis Pharma, Co-President, International Pharmaceutical Congress Advisory Association (IPCAA), Berne, Switzerland Ilana Shulman, Esq. Associate General Counsel, Legal and Compliance, Astellas US LLC, Northbrook, IL, USA Heather Simmonds Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK Robert Skinner Deputy Compliance Officer, Emerging Markets, Asia Pacific and Japan, GlaxoSmithKline, Chalfont St. Giles, Buckinghamshire, UK David Stainback Director Pharmaceutical and Life Sciences Advisory, PwC, Atlanta, GA, USA Joseph B. Tompkins, Jr. Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA Vincent M. Walden, CFE, CITP Partner, Fraud Investigation & Dispute Services, EY, New York, NY, USA Trevor Wear, MHA, JD Partner, Sidley Austin LLP, Chicago, IL Fatima Wolff, Esq. Senior Compliance Counsel, Boston Scientific Corporation, Miami, FL, USA David Wysocky Principal, Pharmaceutical and Life Sciences Advisory, PwC, Florham Park, NJ, USA

SECOND LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS AND BEST PRACTICES FORUM